DELCATH ANNOUNCES ODAC MEETING REVIEW DATE FOR ITS PROPRIETARY DRUG/DEVICE COMBINATION PRODUCT DELCATH HEPATIC DELIVERY SYSTEM

DELCATH ANNOUNCES ODAC MEETING REVIEW DATE FOR ITS PROPRIETARY DRUG/DEVICE COMBINATION PRODUCT DELCATH HEPATIC DELIVERY SYSTEM

[at noodls] – Meeting to be Held May 2, 2013 NEW YORK, Feb. 27, 2013 — Delcath Systems, Inc. (NASDAQ: DCTH) today announced that the U.S. Food and Drug Administration’s (FDA) Oncologic Drugs Advisory Committee (ODAC) … more

View todays social media effects on DCTH

View the latest stocks trending across Twitter. Click to view dashboard

See who Delcath is hiring next, click here to view

Share this post